Next Article in Journal
Priorities, Barriers, and Facilitators towards International Guidelines for the Delivery of Supportive Clinical Care during an Ebola Outbreak: A Cross-Sectional Survey
Next Article in Special Issue
Generation and Characterization of Anti-Filovirus Nucleoprotein Monoclonal Antibodies
Previous Article in Journal
Immune System Modulation and Viral Persistence in Bats: Understanding Viral Spillover
Previous Article in Special Issue
Back to the Future for Influenza Preimmunity—Looking Back at Influenza Virus History to Infer the Outcome of Future Infections
Open AccessArticle

In Vivo Characterization of Avian Influenza A (H5N1) and (H7N9) Viruses Isolated from Canadian Travelers

by Yao Lu 1,2,†, Shelby Landreth 1,3,†, Amit Gaba 1, Magda Hlasny 1, Guanqun Liu 1,3, Yanyun Huang 4 and Yan Zhou 1,2,3,*
1
Vaccine and Infectious Disease Organization - International Vaccine Centre (VIDO-InterVac), University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada
2
Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK S7N 5B4, Canada
3
Vaccinology & Immunotherapeutics program, School of Public Health, University of Saskatchewan, Saskatoon, SK S7N 2Z4, Canada
4
Prairie Diagnostic Services Inc., Saskatoon, SK S7N 5B4, Canada
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Viruses 2019, 11(2), 193; https://doi.org/10.3390/v11020193
Received: 22 January 2019 / Revised: 19 February 2019 / Accepted: 20 February 2019 / Published: 23 February 2019
(This article belongs to the Special Issue CSV2018: The 2nd symposium of the Canadian Society for Virology (CSV))
Highly pathogenic avian influenza (HPAI) H5N1 and low pathogenic avian influenza (LPAI) H7N9 viruses pose a severe threat to public health through zoonotic infection, causing severe respiratory disease in humans. While HPAI H5N1 human infections have typically been reported in Asian countries, avian H7N9 human infections have been reported mainly in China. However, Canada reported a case of fatal human infection by the HPAI H5N1 virus in 2014, and two cases of human illness associated with avian H7N9 virus infection in 2015. While the genomes of the causative viruses A/Alberta/01/2014 (H5N1) (AB14 (H5N1)) and A/British Columbia/1/2015 (H7N9) (BC15 (H7N9)) are reported, the isolates had not been evaluated for their pathogenicity in animal models. In this study, we characterized the pathogenicity of AB14 (H5N1) and BC15 (H7N9) and found that both strain isolates are highly lethal in mice. AB14 (H5N1) caused systemic viral infection and erratic proinflammatory cytokine gene expression in different organs. In contrast, BC15 (H7N9) replicated efficiently only in the respiratory tract, and was a potent inducer for proinflammatory cytokine genes in the lungs. Our study provides experimental evidence to complement the specific human case reports and animal models for evaluating vaccine and antiviral candidates against potential influenza pandemics. View Full-Text
Keywords: influenza A virus; H5N1; H7N9; pathogenesis in mice influenza A virus; H5N1; H7N9; pathogenesis in mice
Show Figures

Figure 1

MDPI and ACS Style

Lu, Y.; Landreth, S.; Gaba, A.; Hlasny, M.; Liu, G.; Huang, Y.; Zhou, Y. In Vivo Characterization of Avian Influenza A (H5N1) and (H7N9) Viruses Isolated from Canadian Travelers. Viruses 2019, 11, 193.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop